Filter
1131
Filtered Results: 1131
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
108
New Publications
284
Language
Document type
No document type
520
Studies & Reports
233
Guidelines
192
Manuals
79
Strategic & Response Plan
59
Fact sheets
20
Training Material
14
Situation Updates
8
Resource Platforms
3
Brochures
2
Infographics
1
Countries / Regions
Global
52
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
30
Nigeria
25
South Africa
18
Ghana
17
Sierra Leone
15
Uganda
15
Zimbabwe
14
Bangladesh
14
Ukraine
14
Philippines
13
Nepal
13
Malawi
13
Zambia
12
Tanzania
12
Rwanda
12
Eastern Europe
12
Latin America and the Carribbean
11
Africa
11
Namibia
10
South–East Asia Region
10
Eswatini/ Swaziland
8
Eastern Europe and Central Asia
8
Liberia
7
Syria
7
Indonesia
7
Myanmar / Burma
7
Botswana
6
West and Central Africa
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Egypt
3
Middle East and North Africa
3
Western Pacific Region
3
Asia
3
Congo, Democratic Republic of
2
Cameroon
2
Jordan
2
Germany
2
Lebanon
2
Sudan
2
Benin
2
North Macedonia
2
Serbia
2
Lesotho
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
Vietnam
2
North America
2
Jamaica
2
United Kingdom
2
Guinea
1
Mali
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Afghanistan
1
China
1
Mozambique
1
Papua New Guinea
1
Libya
1
Madagascar
1
Chile
1
Fiji
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
383
Clinical Guidelines
107
Public Health
69
Key Resources
44
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
9
Toolboxes
AMR
136
Pharmacy
133
COVID-19
81
TB
57
Mental Health
56
HIV
52
Rapid Response
48
Planetary Health
27
Caregiver
26
Global Health Education
25
Conflict
22
NCDs
22
NTDs
21
Health Financing Toolbox
16
Specific Hazards
12
Ebola
10
Polio
8
Disability
7
Refugee
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NCDs) into existing health programs for HIV/AIDS, tub...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
The active participation and engagement of health and care workers (HCWs) in health emergency preparedness, readiness and response is crucial to support risk communication, community engagement and infodemic management (RCCE-IM) interventions during emergencies. HCWs hold unique position...
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and their links to health, well-being and the broader public health and sustainable development agenda. The need for integrated approaches is increasi...
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a...
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required to offer significant health benefits and mitigate he...
